{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T09:06:21Z","timestamp":1778922381562,"version":"3.51.4"},"reference-count":187,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T00:00:00Z","timestamp":1679529600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"NHLBI","doi-asserted-by":"publisher","award":["1R01HL14681001A1"],"award-info":[{"award-number":["1R01HL14681001A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Sports Medicine and Health Science"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.smhs.2023.03.004","type":"journal-article","created":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T19:26:01Z","timestamp":1680204361000},"page":"209-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["More than a key\u2014the pathological roles of SARS-CoV-2 spike protein in COVID-19 related cardiac injury"],"prefix":"10.1016","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2034-2492","authenticated-orcid":false,"given":"Zhiqiang","family":"Lin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.smhs.2023.03.004_bib1","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.3748\/wjg.v9.i8.1635","article-title":"Current status of severe acute respiratory syndrome in China","volume":"9","author":"Nie","year":"2003","journal-title":"World J Gastroenterol"},{"issue":"19","key":"10.1016\/j.smhs.2023.03.004_bib2","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/22221751.2020.1719902","article-title":"Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan","volume":"9","author":"Chan","year":"2020","journal-title":"Emerg Microb Infect"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib4","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1128\/JVI.79.2.884-895.2005","article-title":"Characterization and complete genome sequence of a novel coronavirus, coronavirus HKU1, from patients with pneumonia","volume":"79","author":"Woo","year":"2005","journal-title":"J\u00a0Virol"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/oxfordjournals.aje.a121171","article-title":"Seroepidemiologic studies of coronavirus infection in adults and children","volume":"91","author":"McIntosh","year":"1970","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s12250-020-00207-4","article-title":"Understanding SARS-CoV-2-mediated inflammatory responses: from mechanisms to potential therapeutic tools","volume":"35","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib7","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.jacbts.2020.04.001","article-title":"The heart in COVID-19: primary target or secondary bystander","volume":"5","author":"Libby","year":"2020","journal-title":"JACC Basic Transl Sci"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41577-020-0308-3","article-title":"COVID-19: immunopathology and its implications for therapy","volume":"20","author":"Cao","year":"2020","journal-title":"Nat Rev Immunol"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib9","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.jacbts.2020.04.002","article-title":"COVID-19 for the cardiologist: basic virology, epidemiology, cardiac manifestations, and potential therapeutic strategies","volume":"5","author":"Atri","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/j.smhs.2023.03.004_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104357","article-title":"Epidemiology and clinical features of COVID-19: a review of current literature","volume":"127","author":"Siordia","year":"2020","journal-title":"J\u00a0Clin Virol"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jamacardio.2020.1017","article-title":"Cardiovascular implications of fatal outcomes of patients with coronavirus disease 2019 (COVID-19)","volume":"5","author":"Guo","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.smhs.2023.03.004_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.103821","article-title":"Clinical predictors of acute cardiac injury and normalization of troponin after hospital discharge from COVID-19","volume":"76","author":"Lu","year":"2022","journal-title":"EBioMedicine"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib13","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in wuhan, China","volume":"5","author":"Shi","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib14","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1161\/CIRCULATIONAHA.122.060632","article-title":"Myocardial involvement after hospitalization for COVID-19 complicated by troponin elevation: a prospective, multicenter, observational study","volume":"147","author":"Artico","year":"2023","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib15","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.jchf.2020.04.001","article-title":"End-stage heart failure with COVID-19: strong evidence of myocardial injury by 2019-nCoV","volume":"8","author":"Dong","year":"2020","journal-title":"JACC Heart Fail"},{"issue":"19","key":"10.1016\/j.smhs.2023.03.004_bib16","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1093\/eurheartj\/ehaa288","article-title":"COVID-19-related myocarditis in a 21-year-old female patient","volume":"41","author":"Kim","year":"2020","journal-title":"Eur Heart J"},{"issue":"10223","key":"10.1016\/j.smhs.2023.03.004_bib17","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.smhs.2023.03.004_bib18","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1503\/cmaj\/051291","article-title":"Troponin: the biomarker of choice for the detection of cardiac injury","volume":"173","author":"Babuin","year":"2005","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"10","key":"10.1016\/j.smhs.2023.03.004_bib19","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1161\/CIRCULATIONAHA.120.051828","article-title":"Microthrombi as a major cause of cardiac injury in COVID-19: a pathologic study","volume":"143","author":"Pellegrini","year":"2021","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib20","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/ejhf.1828","article-title":"Myocardial localization of coronavirus in COVID-19 cardiogenic shock","volume":"22","author":"Tavazzi","year":"2020","journal-title":"Eur J Heart Fail"},{"issue":"Suppl 2","key":"10.1016\/j.smhs.2023.03.004_bib21","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1097\/00005344-199600002-00002","article-title":"Neurohumoral mechanisms in heart failure: a central role for the renin-angiotensin system","volume":"27","author":"Teerlink","year":"1996","journal-title":"J\u00a0Cardiovasc Pharmacol"},{"issue":"11","key":"10.1016\/j.smhs.2023.03.004_bib22","first-page":"1090","article-title":"A\u00a0systematic review of the role of renin angiotensin aldosterone system genes in diabetes mellitus, diabetic retinopathy and diabetic neuropathy","volume":"19","author":"Rahimi","year":"2014","journal-title":"J\u00a0Res Med Sci"},{"key":"10.1016\/j.smhs.2023.03.004_bib23","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/256294","article-title":"Angiotensin-converting enzyme 2 (ACE2) is a key modulator of the renin angiotensin system in health and disease","volume":"2012","author":"Tikellis","year":"2012","journal-title":"Int J Pept"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/10253890802046281","article-title":"Stress, depression and cardiovascular dysregulation: a review of neurobiological mechanisms and the integration of research from preclinical disease models","volume":"12","author":"Grippo","year":"2009","journal-title":"Stress"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib25","article-title":"Takotsubo cardiomyopathy: medical and psychiatric aspects. Role of psychotropic medications in the treatment of adults with \u201cbroken heart\u201d syndrome","volume":"11","author":"Zvonarev","year":"2019","journal-title":"Cureus"},{"issue":"13","key":"10.1016\/j.smhs.2023.03.004_bib26","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1161\/CIRCULATIONAHA.118.037975","article-title":"Myocardial and systemic inflammation in acute stress-induced (Takotsubo) cardiomyopathy","volume":"139","author":"Scally","year":"2019","journal-title":"Circulation"},{"issue":"7798","key":"10.1016\/j.smhs.2023.03.004_bib27","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","article-title":"A\u00a0pneumonia outbreak associated with a new coronavirus of probable bat origin","volume":"579","author":"Zhou","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.smhs.2023.03.004_bib28","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.847809","article-title":"Plasma angiotensin II is increased in critical coronavirus disease 2019","volume":"9","author":"Camargo","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"19","key":"10.1016\/j.smhs.2023.03.004_bib29","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1093\/eurheartj\/ehaa286","article-title":"Acute myocarditis presenting as a reverse Tako-Tsubo syndrome in a patient with SARS-CoV-2 respiratory infection","volume":"41","author":"Sala","year":"2020","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib30","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1378\/chest.101.6.1644","article-title":"Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP\/SCCM consensus conference committee. American college of chest physicians\/society of critical care medicine","volume":"101","author":"Bone","year":"1992","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib31","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.18295\/2075-0528.1676","article-title":"The role of damage-associated molecular patterns (DAMPs) in human diseases: Part II: DAMPs as diagnostics, prognostics and therapeutics in clinical medicine","volume":"15","author":"Land","year":"2015","journal-title":"Sultan Qaboos Univ Med J"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib32","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a006049","article-title":"Signaling in innate immunity and inflammation","volume":"4","author":"Newton","year":"2012","journal-title":"Cold Spring Harbor Perspect Biol"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib33","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/SHK.0b013e31820fe5d5","article-title":"Effects of a potent peroxynitrite decomposition catalyst in murine models of endotoxemia and sepsis","volume":"35","author":"Soriano","year":"2011","journal-title":"Shock"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib34","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41379-020-0536-x","article-title":"Pathological study of the 2019 novel coronavirus disease (COVID-19) through postmortem core biopsies","volume":"33","author":"Tian","year":"2020","journal-title":"Mod Pathol"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib35","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-2600(20)30243-5","article-title":"Pulmonary and cardiac pathology in African American patients with COVID-19: an autopsy series from New Orleans","volume":"8","author":"Fox","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib36","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.3390\/microorganisms10051050","article-title":"SARS CoV-2-Induced viral sepsis: the role of gut barrier dysfunction","volume":"10","author":"Assimakopoulos","year":"2022","journal-title":"Microorganisms"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib37","first-page":"11","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo","year":"2020","journal-title":"Mil Med Res"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.7326\/0003-4819-113-3-227","article-title":"Septic shock in humans. Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy","volume":"113","author":"Parrillo","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.smhs.2023.03.004_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s40560-016-0148-1","article-title":"Sepsis-induced myocardial dysfunction: pathophysiology and management","volume":"4","author":"Kakihana","year":"2016","journal-title":"J\u00a0Intensive Care"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib40","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/01.CCM.0000190622.02222.DF","article-title":"Endotoxin-induced heart dysfunction in rats: assessment of myocardial perfusion and permeability and the role of fluid resuscitation","volume":"34","author":"Chagnon","year":"2006","journal-title":"Crit Care Med"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib41","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1161\/01.RES.0000124395.20249.AE","article-title":"Cardiac myocytes activated by septic plasma promote neutrophil transendothelial migration: role of platelet-activating factor and the chemokines LIX and KC","volume":"94","author":"Madorin","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.smhs.2023.03.004_bib42","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3389\/fimmu.2017.01021","article-title":"Sepsis-induced cardiomyopathy: mechanisms and treatments","volume":"8","author":"Liu","year":"2017","journal-title":"Front Immunol"},{"issue":"33","key":"10.1016\/j.smhs.2023.03.004_bib43","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1093\/eurheartj\/eht210","article-title":"Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases","volume":"34","author":"Caforio","year":"2013","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib44","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ehf2.13136","article-title":"Myocardial injury in severe COVID-19 is similar to pneumonias of other origin: results from a multicentre study","volume":"8","author":"Jirak","year":"2021","journal-title":"ESC Heart Fail"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib45","article-title":"Myocardial inflammation and dysfunction in COVID-19\u2013associated myocardial injury","volume":"14","author":"Weckbach","year":"2021","journal-title":"Cir Cardiovasc Imag"},{"issue":"15","key":"10.1016\/j.smhs.2023.03.004_bib46","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1161\/CIRCULATIONAHA.121.056817","article-title":"Prevalence, characteristics, and outcomes of COVID-19\u2013associated acute myocarditis","volume":"145","author":"Ammirati","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.smhs.2023.03.004_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ijid.2021.08.015","article-title":"SARS-CoV-2 is localized in cardiomyocytes: a postmortem biopsy case","volume":"111","author":"Nakamura","year":"2021","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib48","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1007\/s00414-020-02500-z","article-title":"SARS-Cov-2 fulminant myocarditis: an autopsy and histopathological case study","volume":"135","author":"Gauchotte","year":"2021","journal-title":"Int J Leg Med"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib49","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.jacbts.2021.01.002","article-title":"SARS-CoV-2 infects human engineered heart tissues and models COVID-19 myocarditis","volume":"6","author":"Bailey","year":"2021","journal-title":"JACC Basic Transl Sci"},{"issue":"9","key":"10.1016\/j.smhs.2023.03.004_bib50","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/s41569-020-0413-9","article-title":"COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives","volume":"17","author":"Nishiga","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib51","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/ACO.0000000000000559","article-title":"Oxygen in the critically ill: friend or foe","volume":"31","author":"Damiani","year":"2018","journal-title":"Curr Opin Anaesthesiol"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib52","first-page":"1979","article-title":"PEDF decreases cardiomyocyte edema during oxygen-glucose deprivation and recovery via inhibiting lactate accumulation and expression of AQP1","volume":"43","author":"Huang","year":"2019","journal-title":"Int J Mol Med"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib53","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.3892\/ijmm.2016.2783","article-title":"Asiatic acid inhibits lactate-induced cardiomyocyte apoptosis through the regulation of the lactate signaling cascade","volume":"38","author":"Gao","year":"2016","journal-title":"Int J Mol Med"},{"issue":"6\u20137","key":"10.1016\/j.smhs.2023.03.004_bib54","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/j.bbabio.2010.02.011","article-title":"Hypoxia and mitochondrial oxidative metabolism","volume":"1797","author":"Solaini","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.smhs.2023.03.004_bib55","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1941285","article-title":"The good, the bad, and the ugly of ROS: new insights on aging and aging-related diseases from eukaryotic and prokaryotic model organisms","volume":"2018","author":"Santos","year":"2018","journal-title":"Oxid Med Cell Longev"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.15420\/aer.2015.4.1.28","article-title":"Biology of the sinus Node and its disease","volume":"4","author":"Choudhury","year":"2015","journal-title":"Arrhythmia Electrophysiol Rev"},{"key":"10.1016\/j.smhs.2023.03.004_bib57","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1749-6632.1999.tb11353.x","article-title":"The HCN gene family: molecular basis of the hyperpolarization-activated pacemaker channels","volume":"868","author":"Santoro","year":"1999","journal-title":"Ann N Y Acad Sci"},{"issue":"9","key":"10.1016\/j.smhs.2023.03.004_bib58","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/ncpcardio0309","article-title":"Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure","volume":"2","author":"Feldman","year":"2005","journal-title":"Nat Clin Pract Cardiovasc Med"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib59","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0008-6363(01)00370-4","article-title":"Properties of the hyperpolarization-activated current (I(f)) in isolated mouse sino-atrial cells","volume":"52","author":"Mangoni","year":"2001","journal-title":"Cardiovasc Res"},{"issue":"4973","key":"10.1016\/j.smhs.2023.03.004_bib60","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1126\/science.1697697","article-title":"Heart rate regulation by G proteins acting on the cardiac pacemaker channel","volume":"249","author":"Yatani","year":"1990","journal-title":"Science"},{"issue":"13","key":"10.1016\/j.smhs.2023.03.004_bib61","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.3390\/ijms22136649","article-title":"YAP\/TEAD1 complex is a default repressor of cardiac toll-like receptor genes","volume":"22","author":"Gao","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib62","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3390\/vaccines5040034","article-title":"TLR4 signaling pathway modulators as potential therapeutics in inflammation and sepsis","volume":"5","author":"Kuzmich","year":"2017","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.smhs.2023.03.004_bib63","doi-asserted-by":"crossref","first-page":"603","DOI":"10.3389\/fendo.2019.00603","article-title":"TLR4\/NF-\u03baB signaling induces GSDMD-related pyroptosis in tubular cells in diabetic kidney disease","volume":"10","author":"Wang","year":"2019","journal-title":"Front Endocrinol"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib64","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1038\/nrmicro2070","article-title":"Pyroptosis: host cell death and inflammation","volume":"7","author":"Bergsbaken","year":"2009","journal-title":"Nat Rev Microbiol"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib65","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.yjmcc.2010.02.020","article-title":"Cardiomyocyte Toll-like receptor 4 is involved in heart dysfunction following septic shock or myocardial ischemia","volume":"48","author":"Fallach","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib66","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.4049\/jimmunol.146.5.1437","article-title":"Tissue factor expression in endothelial cell\/monocyte cocultures stimulated by lipopolysaccharide and\/or aggregated IgG. Mechanisms of cell:cell communication","volume":"146","author":"Wharram","year":"1991","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib67","first-page":"301","article-title":"IL-1 and IFN-gamma increase vascular permeability","volume":"64","author":"Martin","year":"1988","journal-title":"Immunology"},{"issue":"11","key":"10.1016\/j.smhs.2023.03.004_bib68","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11886-018-1067-7","article-title":"Tumor necrosis factor-\u03b1 in heart failure: an updated review","volume":"20","author":"Schumacher","year":"2018","journal-title":"Curr Cardiol Rep"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib69","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.cyto.2008.07.017","article-title":"An overview of IL-17 function and signaling","volume":"43","author":"Gaffen","year":"2008","journal-title":"Cytokine"},{"issue":"suppl 1","key":"10.1016\/j.smhs.2023.03.004_bib70","doi-asserted-by":"crossref","first-page":"i90","DOI":"10.1136\/ard.59.suppl_1.i90","article-title":"Activation of cytokines as a mechanism of disease progression in heart failure","volume":"59","author":"Bozkurt","year":"2000","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib71","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.smhs.2023.03.004_bib72","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12933-015-0288-y","article-title":"Circulating interleukin-1\u03b2 promotes endoplasmic reticulum stress-induced myocytes apoptosis in diabetic cardiomyopathy via interleukin-1 receptor-associated kinase-2","volume":"14","author":"Liu","year":"2015","journal-title":"Cardiovasc Diabetol"},{"issue":"32","key":"10.1016\/j.smhs.2023.03.004_bib73","doi-asserted-by":"crossref","first-page":"21896","DOI":"10.1074\/jbc.M114.549642","article-title":"Interleukin-1\u03b2 reduces L-type Ca2+ current through protein kinase C\u03b5 activation in mouse heart","volume":"289","author":"El Khoury","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.smhs.2023.03.004_bib74","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13344","article-title":"Macrophage-dependent IL-1\u03b2 production induces cardiac arrhythmias in diabetic mice","volume":"7","author":"Monnerat","year":"2016","journal-title":"Nat Commun"},{"issue":"11","key":"10.1016\/j.smhs.2023.03.004_bib75","doi-asserted-by":"crossref","first-page":"20453","DOI":"10.1002\/jcp.28647","article-title":"Inflammatory cytokines associated with cancer growth induce mitochondria and cytoskeleton alterations in cardiomyocytes","volume":"234","author":"Buoncervello","year":"2019","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.smhs.2023.03.004_bib76","author":"Vincent"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib77","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib78","doi-asserted-by":"crossref","first-page":"H2408","DOI":"10.1152\/ajpheart.01150.2006","article-title":"Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis","volume":"292","author":"Zhang","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"3\u20134","key":"10.1016\/j.smhs.2023.03.004_bib79","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bbrc.2017.10.119","article-title":"Interleukin-6 deficiency attenuates angiotensin II-induced cardiac pathogenesis with increased myocyte hypertrophy","volume":"494","author":"Chen","year":"2017","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib80","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.cardiores.2005.08.017","article-title":"IL-6 induces PI 3-kinase and nitric oxide-dependent protection and preserves mitochondrial function in cardiomyocytes","volume":"69","author":"Smart","year":"2006","journal-title":"Cardiovasc Res"},{"issue":"18","key":"10.1016\/j.smhs.2023.03.004_bib81","doi-asserted-by":"crossref","first-page":"16304","DOI":"10.1074\/jbc.M212321200","article-title":"JAK2\/STAT3, not ERK1\/2, mediates interleukin-6-induced activation of inducible nitric-oxide synthase and decrease in contractility of adult ventricular myocytes","volume":"278","author":"Yu","year":"2003","journal-title":"J\u00a0Biol Chem"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib82","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.immuni.2019.03.026","article-title":"Targeting interleukin-6 signaling in clinic","volume":"50","author":"Kang","year":"2019","journal-title":"Immunity"},{"issue":"5 Suppl","key":"10.1016\/j.smhs.2023.03.004_bib83","first-page":"456","article-title":"The role of interleukin-8 in inflammation and mechanisms of regulation","volume":"64","author":"Bickel","year":"1993","journal-title":"J\u00a0Periodontol"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib84","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1586\/1744666X.2014.894886","article-title":"The CXCL8\/IL-8 chemokine family and its receptors in inflammatory diseases","volume":"10","author":"Russo","year":"2014","journal-title":"Expet Rev Clin Immunol"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib85","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1172\/JCI117680","article-title":"Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo","volume":"95","author":"Kukielka","year":"1995","journal-title":"J\u00a0Clin Invest"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib86","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s40425-019-0706-x","article-title":"Phase I trial of HuMax-IL8 (BMS-986253), an anti-IL-8 monoclonal antibody, in patients with metastatic or unresectable solid tumors","volume":"7","author":"Bilusic","year":"2019","journal-title":"J\u00a0Immunother Cancer"},{"issue":"11","key":"10.1016\/j.smhs.2023.03.004_bib87","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1016\/j.bbamcr.2016.08.013","article-title":"Interleukin-17A mediates cardiomyocyte apoptosis through Stat3-iNOS pathway","volume":"1863","author":"Su","year":"2016","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib88","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1056\/NEJMoa1314258","article-title":"Secukinumab in plaque psoriasis--results of two phase 3 trials","volume":"371","author":"Langley","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib89","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.cyto.2015.05.030","article-title":"GM-CSF: an immune modulatory cytokine that can suppress autoimmunity","volume":"75","author":"Bhattacharya","year":"2015","journal-title":"Cytokine"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib90","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1734-1140(12)70860-5","article-title":"Granulocyte colony-stimulating factor improves early remodeling in isoproterenol-induced cardiac injury in rats","volume":"64","author":"Forechi","year":"2012","journal-title":"Pharmacol Rep"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib91","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/j.1582-4934.2008.00294.x","article-title":"Effect of a long-term treatment with a low-dose granulocyte colony-stimulating factor on post-infarction process in the heart","volume":"12","author":"Okada","year":"2008","journal-title":"J\u00a0Cell Mol Med"},{"issue":"11","key":"10.1016\/j.smhs.2023.03.004_bib92","doi-asserted-by":"crossref","first-page":"E427","DOI":"10.1503\/cmaj.140133","article-title":"Granulocyte colony-stimulating factor therapy for stem cell mobilization following anterior wall myocardial infarction: the CAPITAL STEM MI randomized trial","volume":"186","author":"Hibbert","year":"2014","journal-title":"CMAJ (Can Med Assoc J)"},{"issue":"11","key":"10.1016\/j.smhs.2023.03.004_bib93","doi-asserted-by":"crossref","first-page":"3293","DOI":"10.1084\/jem.20170689","article-title":"The infarcted myocardium solicits GM-CSF for the detrimental oversupply of inflammatory leukocytes","volume":"214","author":"Anzai","year":"2017","journal-title":"J\u00a0Exp Med"},{"issue":"10","key":"10.1016\/j.smhs.2023.03.004_bib94","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1084\/jem.20151853","article-title":"GM-CSF primes cardiac inflammation in a mouse model of Kawasaki disease","volume":"213","author":"Stock","year":"2016","journal-title":"J\u00a0Exp Med"},{"issue":"50","key":"10.1016\/j.smhs.2023.03.004_bib95","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000002044","article-title":"A\u00a0review of GM-CSF therapy in sepsis","volume":"94","author":"Mathias","year":"2015","journal-title":"Medicine (Baltim)"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib96","first-page":"121","article-title":"CXCL10\/IP-10 in infectious diseases pathogenesis and potential therapeutic implications","volume":"22","author":"Liu","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib97","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1161\/CIRCRESAHA.108.192179","article-title":"CXCL10 inhibits viral replication through recruitment of natural killer cells in coxsackievirus B3-induced myocarditis","volume":"104","author":"Yuan","year":"2009","journal-title":"Circ Res"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib98","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1136\/gutjnl-2012-303424","article-title":"Anti-IP-10 antibody (BMS-936557) for ulcerative colitis: a phase II randomised study","volume":"63","author":"Mayer","year":"2014","journal-title":"Gut"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib99","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/ecco-jcc\/jjv224","article-title":"Eldelumab [Anti-IP-10] induction therapy for ulcerative colitis: a randomised, placebo-controlled, phase 2b study","volume":"10","author":"Sandborn","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib100","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1089\/jir.2008.0027","article-title":"Monocyte chemoattractant protein-1 (MCP-1): an overview","volume":"29","author":"Deshmane","year":"2009","journal-title":"J\u00a0Interferon Cytokine Res"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib101","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0002-9440(10)63309-3","article-title":"Targeted deletion of CC chemokine receptor 2 attenuates left ventricular remodeling after experimental myocardial infarction","volume":"165","author":"Kaikita","year":"2004","journal-title":"Am J Pathol"},{"issue":"8","key":"10.1016\/j.smhs.2023.03.004_bib102","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/01.RES.0000163017.13772.3a","article-title":"CCL2\/Monocyte Chemoattractant Protein-1 regulates inflammatory responses critical to healing myocardial infarcts","volume":"96","author":"Dewald","year":"2005","journal-title":"Circ Res"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib103","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/107999001750277862","article-title":"An anti-inflammatory drug, propagermanium, may target GPI-anchored proteins associated with an MCP-1 receptor, CCR2","volume":"21","author":"Yokochi","year":"2001","journal-title":"J\u00a0Interferon Cytokine Res"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib104","doi-asserted-by":"crossref","first-page":"4004","DOI":"10.1128\/JVI.77.7.4004-4014.2003","article-title":"CC chemokine ligand 3 (CCL3) regulates CD8(+)-T-cell effector function and migration following viral infection","volume":"77","author":"Trifilo","year":"2003","journal-title":"J\u00a0Virol"},{"issue":"18","key":"10.1016\/j.smhs.2023.03.004_bib105","doi-asserted-by":"crossref","first-page":"10840","DOI":"10.1128\/JVI.01524-14","article-title":"Chemokine (C-C Motif) receptor 1 is required for efficient recruitment of neutrophils during respiratory infection with modified vaccinia virus Ankara","volume":"88","author":"Price","year":"2014","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.smhs.2023.03.004_bib106","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3389\/fimmu.2020.00306","article-title":"CCL3\/Macrophage inflammatory protein-1\u03b1 is dually involved in parasite persistence and induction of a TNF- and IFN\u03b3-enriched inflammatory milieu in trypanosoma cruzi-induced chronic cardiomyopathy","volume":"11","author":"Gibaldi","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.smhs.2023.03.004_bib107","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41392-017-0002-5","article-title":"Targeting IL-2: an unexpected effect in treating immunological diseases","volume":"3","author":"Ye","year":"2018","journal-title":"Signal Transduct Targeted Ther"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib108","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1172\/JCI114783","article-title":"Effects of interleukin 2 on cardiac function in the isolated rat heart","volume":"86","author":"Sobotka","year":"1990","journal-title":"J\u00a0Clin Invest"},{"issue":"12","key":"10.1016\/j.smhs.2023.03.004_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3001016","article-title":"The SARS-CoV-2 Spike protein has a broad tropism for mammalian ACE2 proteins","volume":"18","author":"Conceicao","year":"2020","journal-title":"PLoS Biol"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","article-title":"Mechanisms of SARS-CoV-2 entry into cells","volume":"23","author":"Jackson","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"19","key":"10.1016\/j.smhs.2023.03.004_bib111","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/CIRCULATIONAHA.120.050097","article-title":"The enemy within: sudden-onset reversible cardiogenic shock with biopsy-proven cardiac myocyte infection by severe acute respiratory syndrome coronavirus 2","volume":"142","author":"Albert","year":"2020","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.smhs.2023.03.004_bib112","doi-asserted-by":"crossref","first-page":"626","DOI":"10.3390\/biomedicines8120626","article-title":"Evidence of SARS-CoV-2 transcriptional activity in cardiomyocytes of COVID-19 patients without clinical signs of cardiac involvement","volume":"8","author":"Bulfamante","year":"2020","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.smhs.2023.03.004_bib113","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2352-4642(20)30257-1","article-title":"SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome","volume":"4","author":"Dolhnikoff","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"issue":"8","key":"10.1016\/j.smhs.2023.03.004_bib114","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41374-022-00783-x","article-title":"Characterization of COVID-19-associated cardiac injury: evidence for a multifactorial disease in an autopsy cohort","volume":"102","author":"Hanson","year":"2022","journal-title":"Lab Invest"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1009705","article-title":"SARS-CoV-2 infection in the Syrian hamster model causes inflammation as well as type I interferon dysregulation in both respiratory and non-respiratory tissues including the heart and kidney","volume":"17","author":"Francis","year":"2021","journal-title":"PLoS Pathog"},{"issue":"9","key":"10.1016\/j.smhs.2023.03.004_bib116","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.stemcr.2021.07.012","article-title":"Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2","volume":"16","author":"Yang","year":"2021","journal-title":"Stem Cell Rep"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib117","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1161\/CIRCRESAHA.121.320518","article-title":"SARS-CoV-2 infection induces ferroptosis of sinoatrial Node pacemaker cells","volume":"130","author":"Han","year":"2022","journal-title":"Circ Res"},{"issue":"590","key":"10.1016\/j.smhs.2023.03.004_bib118","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abf7872","article-title":"SARS-CoV-2 infection of human iPSC-derived cardiac cells reflects cytopathic features in hearts of patients with COVID-19","volume":"13","author":"Perez-Bermejo","year":"2021","journal-title":"Sci Transl Med"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib119","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.stemcr.2021.02.008","article-title":"SARS-CoV-2 infects human pluripotent stem cell-derived cardiomyocytes, impairing electrical and mechanical function","volume":"16","author":"Marchiano","year":"2021","journal-title":"Stem Cell Rep"},{"issue":"14","key":"10.1016\/j.smhs.2023.03.004_bib120","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1093\/cvr\/cvaa267","article-title":"SARS-CoV-2 infects and induces cytotoxic effects in human cardiomyocytes","volume":"116","author":"Bojkova","year":"2020","journal-title":"Cardiovasc Res"},{"issue":"24","key":"10.1016\/j.smhs.2023.03.004_bib121","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1042\/CS20210735","article-title":"The SARS-CoV-2 Spike protein disrupts human cardiac pericytes function through CD147 receptor-mediated signalling: a potential non-infective mechanism of COVID-19 microvascular disease","volume":"135","author":"Avolio","year":"2021","journal-title":"Clin Sci (Lond)"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib122","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.stemcr.2022.01.015","article-title":"A\u00a0human pluripotent stem cell-based model of SARS-CoV-2 infection reveals an ACE2-independent inflammatory activation of vascular endothelial cells through TLR4","volume":"17","author":"Ma","year":"2022","journal-title":"Stem Cell Rep"},{"issue":"24","key":"10.1016\/j.smhs.2023.03.004_bib123","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01368-21","article-title":"Highly efficient SARS-CoV-2 infection of human cardiomyocytes: spike protein-mediated cell fusion and its inhibition","volume":"95","author":"Navaratnarajah","year":"2021","journal-title":"J\u00a0Virol"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib124","article-title":"Human iPSC-derived cardiomyocytes are susceptible to SARS-CoV-2 infection","volume":"1","author":"Sharma","year":"2020","journal-title":"Cell Rep Med"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib125","first-page":"108","article-title":"Direct mechanisms of SARS-CoV-2-induced cardiomyocyte damage: an update","volume":"19","author":"Yang","year":"2022","journal-title":"J\u00a0Virol"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib126","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1038\/s41467-021-22905-7","article-title":"SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes","volume":"12","author":"Jungreis","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.smhs.2023.03.004_bib127","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.708264","article-title":"SARS-CoV-2 accessory proteins in viral pathogenesis: knowns and unknowns","volume":"12","author":"Redondo","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib128","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"issue":"6511","key":"10.1016\/j.smhs.2023.03.004_bib129","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1126\/science.abd4251","article-title":"Distinct conformational states of SARS-CoV-2 spike protein","volume":"369","author":"Cai","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.smhs.2023.03.004_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100306","article-title":"SARS-CoV-2 infects cells after viral entry via clathrin-mediated endocytosis","volume":"296","author":"Bayati","year":"2021","journal-title":"J\u00a0Biol Chem"},{"issue":"33","key":"10.1016\/j.smhs.2023.03.004_bib131","doi-asserted-by":"crossref","first-page":"11876","DOI":"10.1073\/pnas.0505577102","article-title":"Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry","volume":"102","author":"Simmons","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib132","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/s41392-021-00558-8","article-title":"Cathepsin L plays a key role in SARS-CoV-2 infection in humans and humanized mice and is a promising target for new drug development","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct Targeted Ther"},{"issue":"23","key":"10.1016\/j.smhs.2023.03.004_bib133","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2020106267","article-title":"Syncytia formation by SARS-CoV-2-infected cells","volume":"39","author":"Buchrieser","year":"2020","journal-title":"EMBO J"},{"issue":"7861","key":"10.1016\/j.smhs.2023.03.004_bib134","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41586-021-03491-6","article-title":"Drugs that inhibit TMEM16 proteins block SARS-CoV-2 spike-induced syncytia","volume":"594","author":"Braga","year":"2021","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib135","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.tig.2013.01.011","article-title":"Genetic basis of cell\u2013cell fusion mechanisms","volume":"29","author":"Aguilar","year":"2013","journal-title":"Trends Genet"},{"key":"10.1016\/j.smhs.2023.03.004_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2021.100411","article-title":"Flagging fusion: phosphatidylserine signaling in cell-cell fusion","volume":"296","author":"Whitlock","year":"2021","journal-title":"J\u00a0Biol Chem"},{"issue":"7325","key":"10.1016\/j.smhs.2023.03.004_bib137","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/nature09583","article-title":"Calcium-dependent phospholipid scrambling by TMEM16F","volume":"468","author":"Suzuki","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.smhs.2023.03.004_bib138","series-title":"Molecular Biology of the Cell","article-title":"The compartmentalization of cells","author":"Alberts","year":"2002"},{"issue":"12","key":"10.1016\/j.smhs.2023.03.004_bib139","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrcardio.2012.145","article-title":"Altered sarcoplasmic reticulum calcium cycling\u2014targets for heart failure therapy","volume":"9","author":"Kho","year":"2012","journal-title":"Nat Rev Cardiol"},{"issue":"4 Suppl","key":"10.1016\/j.smhs.2023.03.004_bib140","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S1071-9164(96)80062-5","article-title":"SR Ca(2+)-ATPase\/phospholamban in cardiomyocyte function","volume":"2","author":"Tada","year":"1996","journal-title":"J\u00a0Card Fail"},{"issue":"21","key":"10.1016\/j.smhs.2023.03.004_bib141","doi-asserted-by":"crossref","first-page":"11727","DOI":"10.1073\/pnas.2003138117","article-title":"Cell entry mechanisms of SARS-CoV-2","volume":"117","author":"Shang","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib142","doi-asserted-by":"crossref","first-page":"924","DOI":"10.34067\/KID.0002172021","article-title":"Evidence for SARS-CoV-2 spike protein in the urine of COVID-19 patients","volume":"2","author":"George","year":"2021","journal-title":"Kidney"},{"issue":"7","key":"10.1016\/j.smhs.2023.03.004_bib143","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41422-021-00495-9","article-title":"SARS-CoV-2 spike protein interacts with and activates TLR41","volume":"31","author":"Zhao","year":"2021","journal-title":"Cell Res"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib144","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06187","article-title":"SARS-CoV-2 spike protein S1 subunit induces pro-inflammatory responses via Toll-like receptor 4 signaling in murine and human macrophages","volume":"7","author":"Shirato","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.smhs.2023.03.004_bib145","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.68563","article-title":"SARS-CoV-2 spike protein induces inflammation via TLR2-dependent activation of the NF-\u03baB pathway","volume":"10","author":"Khan","year":"2021","journal-title":"Elife"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib146","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.cyto.2008.01.006","article-title":"LPS\/TLR4 signal transduction pathway","volume":"42","author":"Lu","year":"2008","journal-title":"Cytokine"},{"key":"10.1016\/j.smhs.2023.03.004_bib147","doi-asserted-by":"crossref","unstructured":"Negron SG, Kessinger CW, Xu B, Pu WT, Lin Z. Selectively expressing SARS-CoV-2 Spike protein S1 subunit in cardiomyocytes induces cardiac hypertrophy in mice. 2021.","DOI":"10.1101\/2021.06.20.448993"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib148","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1016\/j.immuni.2021.05.006","article-title":"SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2","volume":"54","author":"Lu","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/j.smhs.2023.03.004_bib149","unstructured":"Jeong D-E, McCoy M, Artiles K, et\u00a0al. Assemblies-of-putative-SARS-CoV2-spike-encoding-mRNA-sequences-for-vaccines-BNT-162b2-and-mRNA-1273. 2021."},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib150","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/s41573-021-00163-y","article-title":"Emerging concepts in the science of vaccine adjuvants","volume":"20","author":"Pulendran","year":"2021","journal-title":"Nat Rev Drug Discov"},{"issue":"7872","key":"10.1016\/j.smhs.2023.03.004_bib151","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/s41586-021-03791-x","article-title":"Systems vaccinology of the BNT162b2 mRNA vaccine in humans","volume":"596","author":"Arunachalam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.smhs.2023.03.004_bib152","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.947320","article-title":"Innate immune responses to three doses of the BNT162b2 mRNA SARS-CoV-2 vaccine","author":"Saresella","year":"2022","journal-title":"Front Immunol"},{"issue":"11","key":"10.1016\/j.smhs.2023.03.004_bib153","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1093\/cid\/ciab707","article-title":"Intravenous injection of COVID-19 mRNA vaccine can induce acute myopericarditis in mouse model","volume":"74","author":"Li","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib154","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1093\/cid\/ciab465","article-title":"Circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine antigen detected in the plasma of mRNA-1273 vaccine recipients","volume":"74","author":"Ogata","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.smhs.2023.03.004_bib155","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202215888","article-title":"Spleen tyrosine kinase mediates innate and adaptive immune crosstalk in SARS-CoV-2 mRNA vaccination","volume":"14","author":"Theobald","year":"2022","journal-title":"EMBO Mol Med"},{"issue":"67","key":"10.1016\/j.smhs.2023.03.004_bib156","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.abm5505","article-title":"Innate immunological pathways in COVID-19 pathogenesis","volume":"7","author":"Paludan","year":"2022","journal-title":"Sci Immunol"},{"issue":"9","key":"10.1016\/j.smhs.2023.03.004_bib157","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/ni.1923","article-title":"Complement: a key system for immune surveillance and homeostasis","volume":"11","author":"Ricklin","year":"2010","journal-title":"Nat Immunol"},{"issue":"1","key":"10.1016\/j.smhs.2023.03.004_bib158","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00281-011-0285-5","article-title":"Endothelium--role in regulation of coagulation and inflammation","volume":"34","author":"van Hinsbergh","year":"2012","journal-title":"Semin Immunopathol"},{"issue":"14","key":"10.1016\/j.smhs.2023.03.004_bib159","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1111\/bph.15476","article-title":"Complement, inflammation and thrombosis","volume":"178","author":"Rawish","year":"2021","journal-title":"Br J Pharmacol"},{"issue":"9","key":"10.1016\/j.smhs.2023.03.004_bib160","doi-asserted-by":"crossref","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","article-title":"Molecular intercommunication between the complement and coagulation systems","volume":"185","author":"Amara","year":"2010","journal-title":"J\u00a0Immunol"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib161","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.imbio.2011.07.028","article-title":"Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome","volume":"217","author":"Kerr","year":"2012","journal-title":"Immunobiology"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib162","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa2015432","article-title":"Pulmonary vascular endothelialitis, thrombosis, and angiogenesis in covid-19","volume":"383","author":"Ackermann","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.smhs.2023.03.004_bib163","doi-asserted-by":"crossref","first-page":"e01753","DOI":"10.1128\/mBio.01753-18","article-title":"Complement activation contributes to severe acute respiratory syndrome coronavirus pathogenesis","volume":"9","author":"Gralinski","year":"2018","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib164","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1021\/acscentsci.1c00010","article-title":"Heparan sulfate proteoglycans as attachment factor for SARS-CoV-2","volume":"7","author":"Liu","year":"2021","journal-title":"ACS Cent Sci"},{"issue":"18","key":"10.1016\/j.smhs.2023.03.004_bib165","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1182\/blood.2020008248","article-title":"Direct activation of the alternative complement pathway by SARS-CoV-2 spike proteins is blocked by factor D inhibition","volume":"136","author":"Yu","year":"2020","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib166","doi-asserted-by":"crossref","DOI":"10.1128\/Spectrum.00735-21","article-title":"SARS-CoV-2 spike protein destabilizes microvascular homeostasis","volume":"9","author":"Panigrahi","year":"2021","journal-title":"Microbiol Spectr"},{"key":"10.1016\/j.smhs.2023.03.004_bib167","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.827146","article-title":"SARS-CoV-2 spike protein 1 activates microvascular endothelial cells and complement system leading to platelet aggregation","volume":"13","author":"Perico","year":"2022","journal-title":"Front Immunol"},{"issue":"9","key":"10.1016\/j.smhs.2023.03.004_bib168","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCRESAHA.121.318902","article-title":"SARS-CoV-2 spike protein impairs endothelial function via downregulation of ACE 2","volume":"128","author":"Lei","year":"2021","journal-title":"Circ Res"},{"issue":"17","key":"10.1016\/j.smhs.2023.03.004_bib169","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1161\/CIRCULATIONAHA.120.050354","article-title":"Severe COVID-19 is a microvascular disease","volume":"142","author":"Lowenstein","year":"2020","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.smhs.2023.03.004_bib170","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1038\/s41418-022-01015-x","article-title":"Immune response in COVID-19: what is next","volume":"29","author":"Li","year":"2022","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.smhs.2023.03.004_bib171","series-title":"The Immune System in Health and Disease","article-title":"Principles of innate and adaptive immunity","author":"Janeway","year":"2001"},{"key":"10.1016\/j.smhs.2023.03.004_bib172","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0065-2776(08)60534-9","article-title":"Superantigens and their potential role in human disease","volume":"54","author":"Kotzin","year":"1993","journal-title":"Adv Immunol"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib173","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1046\/j.1365-2567.2000.00088.x","article-title":"Staphylococcal enterotoxin B induces potent cytotoxic activity by intraepithelial lymphocytes","volume":"101","author":"Roberts","year":"2000","journal-title":"Immunology"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib174","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The immunology of multisystem inflammatory syndrome in children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell"},{"issue":"41","key":"10.1016\/j.smhs.2023.03.004_bib175","doi-asserted-by":"crossref","first-page":"25254","DOI":"10.1073\/pnas.2010722117","article-title":"Superantigenic character of an insert unique to SARS-CoV-2 spike supported by skewed TCR repertoire in patients with hyperinflammation","volume":"117","author":"Cheng","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"10.1016\/j.smhs.2023.03.004_bib176","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20211381","article-title":"TIM3+ TRBV11-2 T cells and IFN\u03b3 signature in patrolling monocytes and CD16+ NK cells delineate MIS-C","volume":"219","author":"Hoste","year":"2022","journal-title":"J\u00a0Exp Med"},{"issue":"10","key":"10.1016\/j.smhs.2023.03.004_bib177","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146614","article-title":"HLA class I-associated expansion of TRBV11-2 T cells in multisystem inflammatory syndrome in children","volume":"131","author":"Porritt","year":"2021","journal-title":"J\u00a0Clin Invest"},{"issue":"16","key":"10.1016\/j.smhs.2023.03.004_bib178","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.3390\/cells11162526","article-title":"SARS-CoV-2 spike does not possess intrinsic superantigen-like inflammatory activity","volume":"11","author":"Amormino","year":"2022","journal-title":"Cells"},{"issue":"12","key":"10.1016\/j.smhs.2023.03.004_bib179","first-page":"916","article-title":"SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity","volume":"12","author":"Petruk","year":"2020","journal-title":"J\u00a0Mol Cell Biol"},{"issue":"3","key":"10.1016\/j.smhs.2023.03.004_bib180","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1021\/acsptsci.1c00219","article-title":"Experimental model of pulmonary inflammation induced by SARS-CoV-2 spike protein and endotoxin","volume":"5","author":"Puthia","year":"2022","journal-title":"ACS Pharmacol Transl Sci"},{"issue":"4","key":"10.1016\/j.smhs.2023.03.004_bib181","doi-asserted-by":"crossref","first-page":"390","DOI":"10.3390\/pathogens11040390","article-title":"Superantigens and SARS-CoV-2","volume":"11","author":"Hamdy","year":"2022","journal-title":"Pathogens"},{"key":"10.1016\/j.smhs.2023.03.004_bib182","article-title":"Plasma markers of disrupted gut permeability in severe COVID-19 patients","volume":"12","author":"Giron","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.smhs.2023.03.004_bib183","article-title":"SARS-COV-2 variants: differences and potential of immune evasion","volume":"11","author":"Hirabara","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"7902","key":"10.1016\/j.smhs.2023.03.004_bib184","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41586-022-04442-5","article-title":"Attenuated replication and pathogenicity of SARS-CoV-2 B.1.1.529 Omicron","volume":"603","author":"Shuai","year":"2022","journal-title":"Nature"},{"issue":"7902","key":"10.1016\/j.smhs.2023.03.004_bib185","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1038\/s41586-022-04462-1","article-title":"Attenuated fusogenicity and pathogenicity of SARS-CoV-2 Omicron variant","volume":"603","author":"Suzuki","year":"2022","journal-title":"Nature"},{"issue":"7902","key":"10.1016\/j.smhs.2023.03.004_bib186","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","article-title":"Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity","volume":"603","author":"Meng","year":"2022","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.smhs.2023.03.004_bib187","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1161\/CIRCULATIONAHA.122.061025","article-title":"Circulating spike protein detected in post-COVID-19 mRNA vaccine myocarditis","volume":"147","author":"Yonker","year":"2023","journal-title":"Circulation"}],"container-title":["Sports Medicine and Health Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666337623000240?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666337623000240?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T08:06:24Z","timestamp":1778918784000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666337623000240"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":187,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2666337623000240"],"URL":"https:\/\/doi.org\/10.1016\/j.smhs.2023.03.004","relation":{},"ISSN":["2666-3376"],"issn-type":[{"value":"2666-3376","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"More than a key\u2014the pathological roles of SARS-CoV-2 spike protein in COVID-19 related cardiac injury","name":"articletitle","label":"Article Title"},{"value":"Sports Medicine and Health Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.smhs.2023.03.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Chengdu Sport University. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.","name":"copyright","label":"Copyright"}]}}